Melaleuca alternifolia Cheel (Tea Tree) and Eucalyptus globulus Labill. Essential Oils’ Effectiveness Against an Acanthamoeba polyphaga Strain Responsible for Human Keratitis
Source abstract
Abstract
Among free-living amoebae (FLA), Acanthamoeba polyphaga is an important causal agent of Acanthamoeba keratitis (AK), a severe and potentially sight-threatening condition. The present study evaluated the “in vitro” efficiency of Melaleuca alternifolia Cheel (tea tree) (tea tree oil—TTO) and Eucalyptus globulus Labill. (Eucalyptus essential oil—EEO) essential oils against an Acanthamoeba strain isolated from human keratitis. The Minimum Inhibitory Concentration (MIC) of the EOs and the Fractional Inhibitory Concentration (FIC) Index were used to evaluate the decrease in viable cells of Acanthamoeba over time and at different concentrations of EOs, used alone or in association. A relevant amoebicidal effect emerged during the first hours of exposure for both compounds, and TTO was the most effective. The TTO/EEO association clearly indicated a synergistic effect in all tests, and at 2 days post-treatment, no viable A. polyphaga cells were observed at all tested concentrations. In conclusion, the potential therapeutic use of EOs represents a promising therapeutic strategy for the treatment of AK.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Essential Oils and Antimicrobial Activity · Phytochemistry and biological activity of medicinal plants · Phytochemistry and Biological Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
Burn Intensive Care Unit, Hospital A. Cardarelli, Via A. Cardarelli 9, 80131 Naples, Italy
References (61)
Show source-provided references
1. Update on Acanthamoeba phylogeny10.1007/s00436-020-06843-9 ↗
2. Putaporntip, C., Kuamsab, N., Nuprasert, W., Rojrung, R., Pattanawong, U., Tia, T., Yanmanee, S., and Jongwutiwes, S. (2021). Analysis of Acanthamoeba genotypes from public freshwater sources in Thailand reveals a new genotype, T23 Acanthamoeba bangkokensis sp. nov. Sci. Rep., 11.10.1038/s41598-021-96690-0 ↗
3. Global prevalence of potentially pathogenic free-living amoebae in sewage and sewage-related environments-systematic review with meta-analysis10.1007/s00436-024-08164-7 ↗
4. Identification and quantification of Acanthamoeba spp. within seawater at four coastal lagoons on the east coast of Australia10.1016/j.scitotenv.2023.165862 ↗
5. Current report on the prevalence of free-living amoebae (FLA) in natural hot springs: A systematic review10.2166/wh.2021.101 ↗
6. Distribution of free-living amoebae (FLA) during preparation and supply of drinking water10.1078/S1438-4639(04)70031-0 ↗
7. Free-living amoebae and their relationship to air quality in hospital environments: Characterization of Acanthamoeba spp. obtained from air-conditioning systems10.1017/S0031182020000487 ↗
8. Prevalence of free-living amoebae in swimming pools and recreational waters, a systematic review and meta-analysis10.1007/s00436-022-07631-3 ↗
9. Wang, Y., Jiang, L., Zhao, Y., Ju, X., Wang, L., Jin, L., Fine, R.D., and Li, M. (2023). Biological characteristics and pathogenicity of Acanthamoeba. Front. Microbiol., 14.10.3389/fmicb.2023.1147077 ↗
10. An update on Acanthamoeba keratitis: Diagnosis, pathogenesis and treatment10.1051/parasite/2015010 ↗
11. The Epidemiology and Clinical Features of Non-Keratitis Acanthamoeba Infections in the United States, 1956–202010.1093/ofid/ofac682 ↗
12. Acanthamoeba and its pathogenic role in granulomatous amebic encephalitis10.1016/j.exppara.2019.107788 ↗
13. Cutaneous acanthamoebiasis in AIDS10.1016/S0190-9622(00)90110-5 ↗
14. Kot, K., Łanocha-Arendarczyk, N., and Kosik-Bogacka, D. (2021). Immunopathogenicity of Acanthamoeba spp. in the brain and lungs. Int. J. Mol. Sci., 22.10.3390/ijms22031261 ↗
15. The global epidemiology and clinical diagnosis of Acanthamoeba keratitis10.1016/j.jiph.2023.03.020 ↗
16. Elsheikha, H.M., Siddiqui, R., and Khan, N.A. (2020). Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs. Pathogens, 9.10.3390/pathogens9050405 ↗
17. Dickson, A., Cooper, E., Fakae, L.B., Wang, B., Chan, K.L.A., and Elsheikha, H.M. (2020). In Vitro Growth- and Encystation-Inhibitory Efficacies of Matcha Green Tea and Epigallocatechin Gallate Against Acanthameoba Castellanii. Pathogens, 9.10.3390/pathogens9090763 ↗
18. In vitro activity of Camellia sinensis (green tea) against trophozoites and cysts of Acanthamoeba castellanii10.1016/j.ijpddr.2020.05.001 ↗
19. Antibacterial properties of plant essential oils10.1016/0168-1605(87)90034-1 ↗
20. Mechanism of action of Spanish oregano, Chinese cinnamon, and savory essential oils against cell membranes and walls of Escherichia coli O157: H7 and Listeria monocytogenes10.4315/0362-028X-69.5.1046 ↗
21. Tyagi, A.K., and Malik, A. (2010). Liquid and vapour-phase antifungal activities of selected essential oils against Candida albicans: Microscopic observations and chemical characterization of Cymbopogon citratus. BMC Complement. Altern. Med., 10.10.1186/1472-6882-10-65 ↗
22. Activity of Melaleuca alternifolia (tea tree) oil on influenza virus A/PR/8: Study on the mechanism of action10.1016/j.antiviral.2010.11.010 ↗
23. Mode of action and variability in efficacy of plant essential oils showing toxicity against the poultry red mite, Dermanyssus gallinae10.1016/j.vetpar.2009.01.010 ↗
24. Iseppi, R., Mariani, M., Benvenuti, S., Truzzi, E., and Messi, P. (2023). Effects of Melaleuca alternifolia Chell (Tea Tree) and Eucalyptus globulus Labill. essential oils on antibiotic-resistant bacterial biofilms. Molecules, 28.10.3390/molecules28041671 ↗
25. Molecular and morphological characterization of Acanthamoeba isolated from corneal scrapes and contact lens wearers in Argentina10.1016/j.meegid.2017.06.031 ↗
26. Protein profiling of Acanthamoeba species using MALDI-TOF MS for specific identification of Acanthamoeba genotype10.1007/s00436-017-5743-0 ↗
27. Targeting Acanthamoeba proteins interaction with flavonoids of propolis extract by in vitro and in silico studies for promising therapeutic effects10.12688/f1000research.126227.1 ↗
28. Synergism between natural products and antibiotics against infectious diseases10.1016/j.phymed.2008.06.008 ↗
29. Anti-Acanthamoeba activity of Tunisian Thymus capitatus essential oil and organic extracts10.1016/j.exppara.2017.09.014 ↗
30. Randag, A.C., van Rooij, J., van Goor, A.T., Verkerk, S., Wisse, R.P.L., Saelens, I.E.Y., Stoutenbeek, R., van Dooren, B.T.H., Cheng, Y.Y.Y., and Eggink, C.A. (2019). The rising incidence of Acanthamoeba keratitis: A 7-year nationwide survey and clinical assessment of risk factors and functional outcomes. PLoS ONE, 14.10.1371/journal.pone.0222092 ↗
31. A Comprehensive review on Acanthamoeba keratitis: An overview of epidemiology, risk factors, and therapeutic strategies
32. Somani, S.N., Ronquillo, Y., and Moshirfar, M. (2024). Acanthamoeba keratitis. StatPearls, StatPearls Publishing.
33. Acanthamoeba keratitis risk factors for daily wear contact lens users: A case-control study10.1016/j.ophtha.2022.08.002 ↗
34. Acanthamoeba keratitis investigation team. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States10.3201/eid1508.0902251 ↗
35. Non-contact lens related Acanthamoeba keratitis10.4103/ijo.IJO_826_17 ↗
36. Acanthamoeba keratitis investigation team. Risk factors for Acanthamoeba keratitis-a multistate case-control study, 2008–201110.1097/ICL.0000000000000365 ↗
37. Amoebicidal activity and chemical composition of Pterocaulon polystachyum (Asteraceae) essential oil10.1007/s00436-011-2383-7 ↗
38. In vitro evaluation of the amoebicidal activity of garlic (Allium sativum) extract on Acanthamoeba castellanii and its cytotoxic potential on corneal cells10.1089/jop.2007.0035 ↗
39. The effect of propolis in experimental Acanthamoeba keratitis10.1111/j.1442-9071.2007.01620.x ↗
40. Bacteriocin-like substance from Bacillus amyloliquefaciens shows remarkable inhibition of Acanthamoeba polyphaga10.1007/s00436-010-2114-5 ↗
41. The Use of Extracts from Passiflora spp. in Helping the Treatment of Acanthamoebiasis
42. Kikowska, M., Kruszka, D., Derda, M., Hadaś, E., and Thiem, B. (2020). Phytochemical Screening and Acanthamoebic activity of shoots from in vitro cultures and in vivo plants of Eryngium alpinum L.-The endangered and protected species. Molecules, 25.10.3390/molecules25061416 ↗
43. Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492)10.1186/s13568-020-0960-9 ↗
44. Leigh-de Rapper, S., Viljoen, A., and van Vuuren, S. (2021). Essential oil blends: The potential of combined use for respiratory tract infections. Antibiotics, 10.10.3390/antibiotics10121517 ↗
45. Simbu, S., Orchard, A., van de Venter, M., and van Vuuren, S. (2024). Ibuprofen as an adjuvant to conventional antimicrobials and essential oil compounds against skin pathogens. J. Appl. Microbiol., 135.10.1093/jambio/lxae186 ↗
46. Efficient therapeutic effect of Nigella sativa aqueous extract and chitosan nanoparticles against experimentally induced Acanthamoeba keratitis10.1007/s00436-019-06359-x ↗
47. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect10.1016/j.exppara.2020.108008 ↗
48. Influence of Legionella pneumophila and other water bacteria on the survival and growth of Acanthamoeba polyphaga10.1007/s00203-010-0618-0 ↗
49. Acanthamoeba polyphaga, a potential environmental vector for the transmission of food-borne and opportunistic pathogens10.1002/jobm.201100097 ↗
50. Protozoa and human macrophages infection by Legionella pneumophila environmental strains belonging to different serogroups10.1007/s00203-012-0858-2 ↗
51. Survival of coliforms and bacterial pathogens within protozoa during chlorination10.1128/aem.54.12.3023-3033.1988 ↗
52. Survival of Campylobacter jejuni in waterborne protozoa10.1128/AEM.71.9.5560-5571.2005 ↗
53. Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion10.1128/iai.62.8.3254-3261.1994 ↗
54. Intraphagocytic growth induces an antibiotic resistant phenotype of Legionella pneumophila10.1128/AAC.39.12.2684 ↗
55. Environmental predators as models for bacterial pathogenesis10.1111/j.1462-2920.2007.01238.x ↗
56. Relationship between Legionella pneumophila and Acanthamoeba polyphaga: Physiological status and susceptibility to chemical inactivation10.1128/aem.58.8.2420-2425.1992 ↗
57. Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials10.1128/AAC.44.7.1990-1994.2000 ↗
58. Ammoides pusilla (Apiaceae) essential oil: Activity against Acanthamoeba castellanii Neff10.1016/j.exppara.2017.10.011 ↗
59. Amebicidal activity of the essential oils of Lippia spp. (Verbenaceae) against Acanthamoeba polyphaga trophozoites10.1007/s00436-015-4769-4 ↗
60. Evaluation of the effectiveness of tea tree oil in treatment of Acanthamoeba infection10.1007/s00436-017-5377-2 ↗
61. Martín-Pérez, T., Heredero-Bermejo, I., Verdú-Expósito, C., and Pérez-Serrano, J. (2021). In vitro evaluation of the combination of Melaleuca alternifolia (tea tree) oil and dimethyl sulfoxide (DMSO) against trophozoites and cysts of Acanthamoeba strains. Oxygen Consumption Rate (OCR) Assay as a Method for Drug Screening. Pathogens, 10.10.3390/pathogens10040491 ↗